By Business/Source
Currency:USD
2025/Q3
Stock NameRevenueRatio
Affordable Medicines460.74M58.73%
AvKARE198.53M25.31%
Specialty125.24M15.96%
By Country/Region
Currency:USD
2024/FY
Stock NameRevenueRatio
United States2.79B100.00%